Clinical Trial

Development of Biomarkers for Monitoring Menopause in Women

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 25, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
This cross-sectional study aims to develop and validate mitochondrial biomarkers for monitoring menopause in women. The study will involve 100 participants divided into three groups: reproductive period, perimenopausal transition period, and postmenopausal period. Peripheral blood samples will be collected, and mitochondrial quality and quantity will be assessed using both qualitative and quantitative analyses. The study will identify potential biomarkers through metabolomics and validate them for monitoring the perimenopausal transition, providing a novel approach for women's health management during menopause.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-24.
Trial Details
NCT Number NCT06852755
Lead Sponsor Fu Jen Catholic University Hospital
Conditions Perimenopausal Biomarkers, Mitochondrial Biomarkers
Enrollment 100 participants
Start Date 2024-07-30
Primary Completion 2026-02 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-05-25